- Home
- PPCB vs NMTC Comparison
PPCB vs NMTC Comparison
Compare PPCB & NMTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PPCB
- NMTC
- Stock Information
- Founded
- PPCB 2007
- NMTC 2009
- Country
- PPCB Australia
- NMTC United States
- Employees
- PPCB N/A
- NMTC N/A
- Industry
- PPCB
- NMTC Medical/Dental Instruments
- Sector
- PPCB
- NMTC Health Care
- Exchange
- PPCB Nasdaq
- NMTC Nasdaq
- Market Cap
- PPCB 39.1M
- NMTC 45.0M
- IPO Year
- PPCB N/A
- NMTC N/A
- Fundamental
- Price
- PPCB $1.91
- NMTC $1.06
- Analyst Decision
- PPCB
- NMTC Strong Buy
- Analyst Count
- PPCB 0
- NMTC 2
- Target Price
- PPCB N/A
- NMTC $2.23
- AVG Volume (30 Days)
- PPCB 316.9K
- NMTC 505.0K
- Earning Date
- PPCB 09-30-2025
- NMTC 08-14-2025
- Dividend Yield
- PPCB N/A
- NMTC N/A
- EPS Growth
- PPCB N/A
- NMTC N/A
- EPS
- PPCB N/A
- NMTC N/A
- Revenue
- PPCB N/A
- NMTC $6,629,051.00
- Revenue This Year
- PPCB N/A
- NMTC $151.98
- Revenue Next Year
- PPCB N/A
- NMTC $31.96
- P/E Ratio
- PPCB N/A
- NMTC N/A
- Revenue Growth
- PPCB N/A
- NMTC 69.00
- 52 Week Low
- PPCB $1.25
- NMTC $0.40
- 52 Week High
- PPCB $145.46
- NMTC $1.39
- Technical
- Relative Strength Index (RSI)
- PPCB N/A
- NMTC 73.51
- Support Level
- PPCB N/A
- NMTC $0.87
- Resistance Level
- PPCB N/A
- NMTC $0.95
- Average True Range (ATR)
- PPCB 0.00
- NMTC 0.07
- MACD
- PPCB 0.00
- NMTC 0.01
- Stochastic Oscillator
- PPCB 0.00
- NMTC 72.06
About PPCB Propanc Biopharma Inc.
Propanc Biopharma Inc is a development-stage healthcare company. It focuses on developing new cancer treatments for patients suffering from pancreatic, ovarian, and colorectal cancer. The company develops a rational, composite formulation of the anti-cancer compound, which together exert a number of effects designed to control or prevent tumors from recurring and spreading through the body. Its product, PRP, is a variation upon its novel formulation and involves proenzymes, the inactive precursors of enzymes.
About NMTC NeuroOne Medical Technologies Corporation
NeuroOne Medical Technologies Corp operates as a medical technology company. It is focused on the development and commercialization of thin-film electrode technology for continuous electroencephalogram (cEEG) and stereoelectrocencephalography (sEEG) recording, brain stimulation, and ablation solutions for patients suffering from brain-related disorders. The company business is in one operating segment, which is the business of development and commercialization of products related to comprehensive neuromodulation cEEG and sEEG recording, monitoring, ablation, and brain stimulation solutions.